Call Us @ 0172 - 4680800 | info@indswift.com | NETWORKS | NSE - BSE
India imported APIs worth Rs 18,372.54 crore in 2016-17
 
India imported Active Pharmaceutical Ingredients (APIs) worth Rs 18,372.54 crore in 2016-17, of which the maximum was from China, Parliament was informed today.

APIs estimated to be worth Rs 12,254.97 crore were imported from China followed by the US at Rs 820.18 crore and Italy at Rs 701.85 crore in 2016-17, the Minister of State for Health Ashwini Kumar Choubey said in the Lok Sabha.

APIs worth Rs 485.11 crore were imported from Germany while APIs Rs 422.01 was imported from Singapore.

API is the term used to refer to the biologically active component of a drug product.

In 2015-16, the country imported APIs worth Rs 21,225.97 crore with ingredients worth Rs 13,853 being imported from China, followed by Germany at Rs 1054.71 crore and the US at Rs 980.38 crore.

(Health World)
 
Other Related News:
2019 FDA Approved Drugs
FDA announces another carcinogenic impurity in ARB blood pressure drugs
Researchers identify common genetic signature among three rare skin diseases
Health ministry to amend Section 71 of D&C Rules to make Pharm D professionals eligible to supervise drug manufacturing
3rd International Diabetes Summit to be held in Pune from March 8-10, 2019
Health ministry to roll out common IT platform for management of sales and manufacturing licenses of drugs
Cosmetics licences may come with product composition details to enhance safety; new clause proposed in Cosmetics Rules 2018
T-cell specificity found to play a role in attacks on myelin versus β-synuclein in MS
Plazomicin noninferior to meropenem for complicated UTI
New molecules reverse memory loss linked to depression, aging